BERKELEY'S NEWS • NOVEMBER 18, 2023
Edward Penhoet
Page 1 of 1
Research & Ideas
MARCH 02, 2022
UC Berkeley loses bitter battle over CRISPR patents
The U.S. Patent Office ruled Monday that patents for some CRISPR technologies do not belong to the university and other partner institutions.
Research & Ideas
MARCH 02, 2022
UC Berkeley loses bitter battle over CRISPR patents
The U.S. Patent Office ruled Monday that patents for some CRISPR technologies do not belong to the university and other partner institutions.
Research & Ideas
NOVEMBER 01, 2018
UC Berkeley announces patenting of gene-editing technology CRISPR
UC Berkeley announced Tuesday that the U.S. Patent and Trademark Office has granted a patent to CRISPR, a gene-editing technology.
Research & Ideas
NOVEMBER 01, 2018
UC Berkeley announces patenting of gene-editing technology CRISPR
UC Berkeley announced Tuesday that the U.S. Patent and Trademark Office has granted a patent to CRISPR, a gene-editing technology.
Campus
JUNE 20, 2018
Team including UC Berkeley researcher awarded patent on CRISPR-Cas9 use in all cells amid pending appeal
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
Campus
JUNE 20, 2018
Team including UC Berkeley researcher awarded patent on CRISPR-Cas9 use in all cells amid pending appeal
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
Research & Ideas
APRIL 03, 2017
European Patent Office intends to grant UC broad patent for CRISPR technology
The European Patent Office, or EPO, announced its intentions to grant the University of California a broad patent for CRISPR-Cas9 gene editing technology in late March.
Research & Ideas
APRIL 03, 2017
European Patent Office intends to grant UC broad patent for CRISPR technology
The European Patent Office, or EPO, announced its intentions to grant the University of California a broad patent for CRISPR-Cas9 gene editing technology in late March.
